MedTrace Logo

Study of Cryotherapy Treatment of Barrett's Esophagus and Early Esophageal Cancer

NCT00321958 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 23

Last updated 2022-02-08

No results posted yet for this study

Summary

The purpose of this study is to confirm the effectiveness and safety of a new medical device which sprays liquid nitrogen through an upper endoscope (cryotherapy) to treat Barrett's esophagus with high-grade dysplasia and early esophageal cancer. It is hypothesized that this treatment will remove the abnormal lining of the esophagus and allow the normal esophageal lining to return.

Conditions

  • Barrett Esophagus
  • Esophageal Neoplasms
  • Deglutition Disorders
  • GERD
  • Neoplasm

Interventions

DEVICE

CSA System (CryoSpray AblationTM System)

10 second spray times

DEVICE

CryoSpray Ablation

10 second spray times

Sponsors & Collaborators

  • CSA Medical, Inc.

    collaborator INDUSTRY

  • University of Maryland, Baltimore

    lead OTHER

Principal Investigators

  • Bruce D Greenwald, M.D. · University of Maryland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2007-05-31
Completion
2007-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00321958 on ClinicalTrials.gov